Prof. Charalambos Antoniades (Professor of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK) kindly shared his thoughts on the fat attenuation index and its use in clinical decision making from the virtual ESC Congress 2021.
Questions
- Can you tell us a little about the fat attenuation index (FAI) and how it can be used in clinical decision making? (0.16)
- What clinical evidence supports the use of the FAI score? (2.45)
- What challenges remain and what future studies are needed? (5.44)
- How can this technology be used in the clinical setting? (7.20)
Speaker disclosures: Prof. Charalambos Antoniades is founder, shareholder and director of Caristo Diagtnostics.
Support: Interview and filming supported by Touch Medical Media and conducted by Heather Hall.
Filmed during a remote video call with Prof. Charalambos Antoniades as a highlight of ESC 2021, August 2021.
